Acasti Pharma Inc. (CVE:ACST – Get Free Report) traded up 1.8% during mid-day trading on Thursday . The company traded as high as C$0.58 and last traded at C$0.58. 2,450 shares were traded during mid-day trading, a decline of 63% from the average session volume of 6,576 shares. The stock had previously closed at C$0.57.
Acasti Pharma Price Performance
The company has a debt-to-equity ratio of 0.52, a quick ratio of 9.41 and a current ratio of 9.74. The stock has a market capitalization of C$25.87 million, a price-to-earnings ratio of -1.07 and a beta of 1.22. The company has a fifty day simple moving average of C$0.58 and a two-hundred day simple moving average of C$0.58.
Acasti Pharma Company Profile
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Recommended Stories
- Five stocks we like better than Acasti Pharma
- How to Invest in the Best Canadian Stocks
- Micron Stock Under $100: Seize the AI-Driven Upside
- What Are Growth Stocks and Investing in Them
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- Overbought Stocks Explained: Should You Trade Them?
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
